SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Antunovic Petar)
 

Sökning: WFRF:(Antunovic Petar) > Characterization an...

  • Hulegardh, ErikDept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, Sweden,Sahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (författare)

Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting : A report from the Swedish Acute Leukemia Registry

  • Artikel/kapitelEngelska2015

Förlag, utgivningsår, omfång ...

  • 2015-01-16
  • Wiley-Blackwell,2015
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-56446
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56446URI
  • https://doi.org/10.1002/ajh.23908DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101381URI
  • https://lup.lub.lu.se/record/5305120URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-239853URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-116506URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:130755580URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agency:Stockholm County CouncilNote:Authors on behalf of the Swedish Acute Myeloid Leukemia Grp (in this document): V. Lazarevic, H. Garelius, P. Antunovic, Å. Rangert Derolf, L. Mollgard, L.Wennström, A. Wahlin, M. Höglund, G. Juliusson, D. Stockelberg, S. Lehmann
  • De två första författarna delar förstaförfattarskapet.
  • Funding Agencies|Stockholm County Council; Swedish Cancer Foundation
  • Patients with secondary acute myeloid leukemia (AML) often escape inclusion in clinical trials and thus, population-based studies are crucial for its accurate characterization. In this first large population-based study on secondary AML, we studied AML with an antecedent hematological disease (AHD-AML) or therapy-related AML (t-AML) in the population-based Swedish Acute Leukemia Registry. The study included 3,363 adult patients of which 2,474 (73.6%) had de novo AML, 630 (18.7%) AHD-AML, and 259 (7.7%) t-AML. Secondary AML differed significantly compared to de novo AML with respect to age, gender, and cytogenetic risk. Complete remission (CR) rates were significantly lower but early death rates similar in secondary AML. In a multivariable analysis, AHD-AML (HR 1.51; 95% CI 1.26-1.79) and t-AML (1.72; 1.38-2.15) were independent risk factors for poor survival. The negative impact of AHD-AML and t-AML on survival was highly age dependent with a considerable impact in younger patients, but without independent prognostic value in the elderly. Although patients with secondary leukemia did poorly with intensive treatment, early death rates and survival were significantly worse with palliative treatment. We conclude that secondary AML in a population-based setting has a striking impact on survival in younger AML patients, whereas it lacks prognostic value among the elderly patients. Am. J. Hematol. 90:208-214, 2015.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Nilsson, ChristerKarolinska Institutet (författare)
  • Lazarevic, VladimirLund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine,Swedish Acute Myeloid Leukemia Grp; Skåne University Hospital, Sweden; Skåne University Hospital, Sweden; Lund University, Sweden(Swepub:lu)med-lzv (författare)
  • Garelius, HegeDept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Swedish Acute Myeloid Leukemia Grp, Linköping Univ Hosp, Linköping, Sweden,Swedish Acute Myeloid Leukemia Grp; Sahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (författare)
  • Antunovic, PetarLinköpings universitet,Medicinska fakulteten,Avdelningen för kliniska vetenskaper,Region Östergötland, Hematologiska kliniken US,Swedish Acute Myeloid Leukemia Grp(Swepub:liu)petan27 (författare)
  • Rangert Derolf, AsaSwedish Acute Myeloid Leukemia Grp, Linköping Univ Hosp, Linköping, Sweden; Ctr Hematol, Karolinska Univ Hosp, Stockholm, Sweden; Reg Tumor Registry, Karolinska Univ Hosp, Stockholm, Sweden,Swedish Acute Myeloid Leukemia Grp; Karolinska University Hospital, Sweden; Karolinska University Hospital, Sweden (författare)
  • Mollgard, LarsDept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Swedish Acute Myeloid Leukemia Grp, Linköping Univ Hosp, Linköping, Sweden,Swedish Acute Myeloid Leukemia Grp; Sahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (författare)
  • Uggla, Bertil,1962-Region Örebro län,Swedish Acute Myeloid Leukemia Group, Linköping, Sweden; Department of Medicine, Örebro University Hospital, Örebro, Sweden(Swepub:oru)bua (författare)
  • Wennström, LovisaDept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Swedish Acute Myeloid Leukemia Grp, Linköping Univ Hosp, Linköping, Sweden,Swedish Acute Myeloid Leukemia Grp; Sahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (författare)
  • Wahlin, AndersUmeå universitet,Institutionen för strålningsvetenskaper,Swedish Acute Myeloid Leukemia Grp; Umeå University, Sweden; Norrland University Hospital, Sweden(Swepub:umu)anwa0027 (författare)
  • Höglund, MartinUppsala universitet,Hematologi,Swedish Acute Myeloid Leukemia Grp; Academic Hospital, Sweden; Academic Hospital, Sweden(Swepub:uu)martinhl (författare)
  • Juliusson, GunnarLund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine,Skåne University Hospital, Sweden; Skåne University Hospital, Sweden; Lund University, Sweden;Swedish Acute Myeloid Leukemia Grp(Swepub:lu)stem-gju (författare)
  • Stockelberg, DickDept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Swedish Acute Myeloid Leukemia Grp, Linköping Univ Hosp, Linköping, Sweden,Swedish Acute Myeloid Leukemia Grp; Sahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (författare)
  • Lehmann, SörenKarolinska Institutet,Uppsala universitet,Hematologi,Swedish Acute Myeloid Leukemia Grp; Karolinska University Hospital, Sweden(Swepub:uu)sorle534 (författare)
  • Swedish Acute Myeloid Leukemia Grp,, Group author (författare)
  • Dept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden; Reg Tumor Registry, Sahlgrenska Univ Hosp, Gothenburg, SwedenSahlgrens University Hospital, Sweden; Sahlgrens University Hospital, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:American Journal of Hematology: Wiley-Blackwell90:3, s. 208-2140361-86091096-8652

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy